Hosted on MSN1mon
Engineers refine lipid nanoparticles for better mRNA therapies
the team's directed evolution process could reduce this timeline to just months or even weeks. "Our hope is that this method will accelerate the pipeline for mRNA therapeutics and vaccines ...
Esphera SynBio closes seed financing round to develop nanomedicine vaccines for cancer and infectious disease
Esphera SynBio ("Esphera"), a synthetic biology company, today announced the closing of a $2M USD seed financing round. The financing builds on the Company's advanced R&D activities and proceeds are ...
Nature11mon
Genetic medicine delivery needs a directed evolution
David Kirn is co-founder and CEO of 4D Molecular Therapeutics (4DMT), a company using directed evolution to invent new adeno-associated virus (AAV) vectors that are tailored to specific target ...